{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:57:53Z","timestamp":1793901473598,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.lungcan.2014.05.010","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T01:32:00Z","timestamp":1400722320000},"page":"191-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: A tissue micro array-based multicenter study"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9803-4476","authenticated-orcid":false,"given":"Rossano","family":"Lattanzio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9992-1296","authenticated-orcid":false,"given":"Rossana","family":"La Sorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Facciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Sioletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libero","family":"Lauriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Martucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovannella","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Evoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Alessandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ruco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erino Angelo","family":"Rendina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Truini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Chiarle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Barreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3175-7797","authenticated-orcid":false,"given":"Achille","family":"Pich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ascani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Remotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Tunesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Granone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Ratto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0165-3965","authenticated-orcid":false,"given":"Francesco","family":"Puma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Pescarmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0154-482X","authenticated-orcid":false,"given":"Mauro","family":"Piantelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0045-0234","authenticated-orcid":false,"given":"Mirella","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Carlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virna","family":"Cerasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicita","family":"Corzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Filippetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Canalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Palestro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Lalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ruffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2014.05.010_bib0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0010","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumors of the lung, pleura, thymus and heart","author":"Travis","year":"2004"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0015","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0025","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","article-title":"Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas","volume":"15","author":"Girard","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0030","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","article-title":"WHO histologic classification is a prognostic indicator in thymoma","volume":"77","author":"Kondo","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","article-title":"The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients","volume":"94","author":"Okumura","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0040","first-page":"367","article-title":"Clinical usefulness of the WHO histological classification of thymoma","volume":"11","author":"Sonobe","year":"2005","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0045","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","article-title":"Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis","volume":"22","author":"Str\u00f6bel","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0050","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.drup.2008.04.001","article-title":"Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents","volume":"11","author":"Le Tourneau","year":"2008","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00280-006-0403-6","article-title":"Challenges for patient selection with VEGF inhibitors","volume":"60","author":"Longo","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1067\/mtc.2002.124389","article-title":"Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors","volume":"124","author":"Tomita","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jso.21277","article-title":"L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas","volume":"99","author":"Kaira","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0085","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/ijc.27751","article-title":"Overexpression of activated phospholipase Cgamma1 is a risk factor for distant metastases in T1-T2 N0 breast cancer patients undergoing adjuvant chemotherapy","volume":"132","author":"Lattanzio","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0090","first-page":"627","article-title":"Angiogenesis in the human thymoma assessed by subclassification of tumor-associated blood vessels and endothelial cells proliferation","volume":"51","author":"Raica","year":"2010","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.aanat.2007.05.003","article-title":"Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus","volume":"190","author":"Cimpean","year":"2008","journal-title":"Ann Anat"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0100","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s005950170021","article-title":"Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms","volume":"31","author":"Sasaki","year":"2001","journal-title":"Surg Today"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0105","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jjco\/hys159","article-title":"Cytoplasmic Trop-1\/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer","volume":"42","author":"Alberti","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0110","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s11605-011-1814-1","article-title":"Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma","volume":"16","author":"Prins","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0115","first-page":"2139","article-title":"Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays","volume":"33","author":"Batistatou","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1514","article-title":"KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas","volume":"202","author":"Pan","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0125","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.7314\/APJCP.2012.13.6.2745","article-title":"Diagnostic and clinical significance of KIT(CD117) expression in thymic epithelial tumors in China","volume":"13","author":"Song","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2006.07.003","article-title":"Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas","volume":"248","author":"Meister","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1309\/2GAYKPDDM85P2VEW","article-title":"Expression of p63 in thymomas and normal thymus","volume":"127","author":"Dotto","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/modpathol.2009.105","article-title":"Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker GLUT-1, in thymic epithelial neoplasms","volume":"22","author":"Kojika","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0145","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2009.27.4662","article-title":"Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors","volume":"28","author":"Kaira","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0150","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1093\/ejcts\/ezt263","volume":"44","author":"Toba","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0155","series-title":"ASCO","article-title":"A phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma","author":"Bedano","year":"2008"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0160","series-title":"ASCO","article-title":"A phase I dose escalation and pharmacokinetic (PK) study of intravenous aflibercept (VEGF trap) plus docetaxel (D) in patients (pts) with advanced solid tumors: preliminary results","author":"Isambert","year":"2008"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0165","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/JTO.0b013e3181a52e25","article-title":"Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma","volume":"4","author":"Bisagni","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0170","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1200\/JCO.2006.08.8963","article-title":"Dasatinib induces a response in malignant thymoma","volume":"24","author":"Chuah","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12032-008-9100-0","article-title":"Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report","volume":"26","author":"Li","year":"2009","journal-title":"Med Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.lungcan.2014.05.010_bib0180","first-page":"S268","article-title":"Clinical activity of sunitinib in patients with thymic carcinoma. 15th WCLC, Sydney, Australia","volume":"8","author":"Thomas","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0185","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/02841860802495362","article-title":"Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma","volume":"48","author":"Azad","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0190","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1158\/1078-0432.CCR-12-2223","article-title":"Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab","volume":"18","author":"Bates","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0195","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1470-2045(07)70141-9","article-title":"Response of thymoma to cetuximab","volume":"8","author":"Farina","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0200","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2741\/2098","article-title":"Cetuximab is an active treatment of metastatic and chemorefractory thymoma","volume":"12","author":"Palmieri","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0205","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/annonc\/mdn388","article-title":"Response of malignant thymoma to erlotinib","volume":"19","author":"Christodoulou","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00280-011-1690-0","article-title":"Imatinib mesylate in thymic epithelial malignancies","volume":"69","author":"Palmieri","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0215","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","article-title":"Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience","volume":"103","author":"Str\u00f6bel","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0220","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/JTO.0b013e3181d86a30","volume":"5","author":"Aisner","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.05.010_bib0225","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1097\/JTO.0b013e3181f209a8","article-title":"Thymoma and thymic carcinoma: molecular pathology and targeted therapy","volume":"5","author":"Str\u00f6bel","year":"2010","journal-title":"J Thorac Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500214002190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500214002190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T21:28:44Z","timestamp":1538602124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500214002190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0169500214002190"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2014.05.010","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: A tissue micro array-based multicenter study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2014.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}